arXiv:2610.25481v2 Announce Type: replace-cross
Abstract: Spatiotemporal forecasting of 3D anatomical changes is a critical generative vision challenge for modeling Alzheimer's Disease (AD) progressi...
By Antonio Scardace, Silvia Ingala, Sebastiano Battiato, Daniele Rav\`i
arXiv:2606. 09907v1 Announce Type: cross Abstract: Multimodal clinical learning is increasingly important for integrating diverse patient data, including imaging, text, and personalised health records.
By Maxx Richard Rahman, Prakhar Kumar, Wolfgang Maass
CoPoE is a new multimodal fusion framework for Alzheimer’s disease diagnosis that maps diverse clinical, imaging, genomic, and biomarker data into a structured latent space divided into four biological and clinical axes: genetic Risk, molecular Pathology, Neurodegeneration, and clinical Stage. Each available modality contributes a diagonal Gaussian expert, and a masked Product-of-Experts architecture fuses only the observed modalities, avoiding synthetic imputation. In extensive experiments on the ADNI dataset, CoPoE outperforms standard missing-modality fusion baselines, achieving higher AUROC, better calibration metrics, and retaining pathology signals even when certain modalities are missing.
By Chihun An, Ikbeom Jang
arXiv:2608. 00073v1 Announce Type: cross Abstract: Rigorous dataset partitioning is a foundational, yet frequently overlooked, prerequisite for reliable deep learning in longitudinal medical imaging.
By Qinghui Liu, Jon Andr\'e Ottesen, Atle Bj{\o}rnerud, Kyrre Eeg Emblem
arXiv:2607. 04647v1 Announce Type: cross Abstract: Scalable Bayesian inference for generalized linear mixed models (GLMMs) provides uncertainty-aware analysis of correlated longitudinal data, but existing scalable approaches largely assume low-dimensional tabular predictors and do not directly accommodate high-dimensional modalities such as images and text.
By Yuankang Zhao, Youngsoo Baek, Felipe A. Medeiros, Samuel Berchuck, Matthew M. Engelhard
arXiv:2606. 15784v1 Announce Type: new Abstract: Alzheimer's disease (AD) progression is often described through the amyloid-tau-neurodegeneration, or AT(N), cascade.
By Nguyen Linh Dan Le